contact us krjpencn


Our Events

현재 위치: > 뉴스현황 > Our Events

  • 03


    Medicilon assisted PA1010 tablets with implied permission for clinical trials

    On March 10, 2020, PA1010 tablets, which are independently developed by Zhejiang Bolaatu Medical Technology Co., Ltd, obtained the implied license for NMPA clinical trials. This is the first new drug declared by Bolaatu.  PA1010 is a new class I drug for chronic hepatitis B (CHB).

  • 02


    Guangzhou Magpie Pharmaceuticals was approved by NMPA to start the clinical trials of MN-08

    Guangzhou Magpie Pharmaceuticals announced the clinical trials of MN-08, a treatment for Idiopathic Pulmonary Artery Hypertension (IPAH).  IPAH is a progressive disease that affects the precapillary pulmonary vasculature.  IPAH is a rare and fatal disease which has a high mortality rate.

  • 02


    Previous Medicilon – Extraordinary “2 0 1 9”

    In 2019, Medicilon has had an extraordinary year. The steadily developing Medicilon made a huge accumulation in 2019 and achieved a qualitative leap.  Let us look back on the moments of glory and Extraordinary “2 0 1 9”.

  • 02


    Medicilon helps to fight the coronavirus by providing funds and technology

    During the Spring Festival, China has been facing a difficult time as the coronavirus spread all over the country.  In order to stop the coronavirus, we look forward to the effective prevention and control to stop the outbreak of the virus and the symptomatic treatment.  We also hope the anti-virus vaccines and drugs could be developed and put into use as soon as possible.

  • 12


    Warmest Holiday Season Greeting From Medicilon

    As the end of year is approaching, we would like to express our sincere gratitude for all your kind business.  Thank you so much for all your trust and support!